Screening and confirmation of 62 drugs of abuse and metabolites in urine by ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry

Journal of Analytical Toxicology

Volumn 37, Issue 9, 2013, Pages 642-651

  Tsai, I Lin ^a,b   Weng, Te I ^a,c   Tseng, Yufeng J ^a,b   Tan, Happy Kuy Lok ^d   Sun, Hsiao Ju ^d   Kuo, Ching Hua ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Department of General Psychiatry   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHOXYAMPHETAMINE; AMINOREX; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTORPHANOL; COCAINE; CODEINE; DIAMORPHINE; DIHYDROCODEINE; EPHEDRINE; FENTANYL; KETAMINE; MEPROBAMATE; METHADONE; METHAMPHETAMINE; METHYLEPHEDRINE; METHYLPHENIDATE; MORPHINE; NALORPHINE; NOREPHEDRINE; PENTAZOCINE; PETHIDINE; PHENTERMINE; PSEUDOEPHEDRINE; TRAMADOL; UNINDEXED DRUG; ZOLPIDEM;

ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DRUG ABUSE; DRUG METABOLISM; DRUG SCREENING; FEMALE; HUMAN; IMMUNOASSAY; IONIZATION; LIMIT OF DETECTION; MALE; METHADONE TREATMENT; NORMAL HUMAN; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ALGORITHMS; AUTOANALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEROIN DEPENDENCE; HUMANS; IMMUNOASSAY; INDICATORS AND REAGENTS; LIMIT OF DETECTION; MASS SPECTROMETRY; METHADONE; NARCOTICS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84885791709     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt083     Document Type: Article

References (26)

1. Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. http://www.samhsa.gov/data/nsduh/ 2k11results/nsduhresults2011.pdf (28 March 2013, date last accessed).
2. European Monitoring Centre for Drugs and Drug Addiction (2009) General Population Surveys of Drug Use-3: Last Year Prevalence of Drug Use among all Adults (Aged 15 to 64 Years) in Nationwide Surveys among the General Population. http://www. emcdda.europa.eu/stats09/gpstab3 (28 March 2013, date last accessed).
3. Gonzalez-Marino, I., Quintana, J.B., Rodriguez, I., Gonzalez-Diez, M., Cela, R. (2012) Screening and selective quantification of illicit drugs in wastewater by mixed-mode solid-phase extraction and quadrupoletime-of-flight liquid chromatography-mass spectrometry. Analytical Chemistry, 84, 1708-1717.
4. Pesce, A., Rosenthal, M., West, R., West, C., Crews, B., Mikel, C. et al. (2010) An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician, 13, 273-281.
5. Weinmann, W., Renz, M., Vogt, S., Pollak, S. (2000) Automated solidphase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS. International Journal of Legal Medicine, 113, 229-235.
6. Marchei, E., Colone, P., Nastasi, G.G., Calabro, C., Pellegrini, M., Pacifici, R. et al. (2008) On-site screening and GC-MS analysis of cocaine and heroin metabolites in body-packers urine. Journal of Pharmaceutical and Biomedical Analysis, 48, 383-387.
7. Saussereau, E., Lacroix, C., Gaulier, J.M., Goulle, J.P. (2012) On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 885, 1-7.
8. Bueno, M.J.M., Ucles, S., Hernando, M.D., Fernandez-Alba, A.R. (2011) Development of a solvent-free method for the simultaneous identification/ quantification of drugs of abuse and their metabolites in environmental water by LC-MS/MS. Talanta, 85, 157-166.
9. Maurer, H.H. (2012) What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? Journal of Chromatography A, doi:10.1016/j.chroma.2012.08.069.
10. Saleh, A., Stephanson, N.N., Granelli, I., Villen, T., Beck, O. (2012) Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 909, 6-13.
11. Lee, H.K., Ho, C.S., Iu, Y.P.H., Lai, P.S.J., Shek, C.C., Lo, Y.C. et al. (2009) Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Analytica Chimica Acta, 649, 80-90.
12. Kolmonen, M., Leinonen, A., Kuuranne, T., Pelander, A., Ojanpera, I. (2009) Generic sample preparation and dual polarity liquid chromatography- time-of-flight mass spectrometry for high-throughput screening in doping analysis. Drug Testing and Analysis, 1, 250-266.
13. Dominguez-Romero, J.C., Garcia-Reyes, J.F., Molina-Diaz, A. (2011) Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 879, 2034-2042.
14. Broecker, S., Herre, S., Wust, B., Zweigenbaum, J., Pragst, F. (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with datadependent acquisition. Analytical and Bioanalytical Chemistry, 400, 101-117.
15. Ojanpera, I., Kolmonen, M., Pelander, A. (2012) Current use of highresolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Analytical and Bioanalytical Chemistry, 403, 1203-1220.
16. Kolmonen, M., Leinonen, A., Pelander, A., Ojanpera, I. (2007) A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Analytica Chimica Acta, 585, 94-102.
17. Pelander, A., Ojanpera, I., Laks, S., Rasanen, I., Vuori, E. (2003) Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. Analytical Chemistry, 75, 5710-5718.
18. Gergov, M., Boucher, B., Ojanpera, I., Vuori, E. (2001) Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Communications in Mass Spectrometry, 15, 521-526.
19. Birkler, R.I.D., Telving, R., Ingemann-Hansen, O., Charles, A.V., Johannsen, M., Andreasen, M.F. (2012) Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultraperformance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)-toxicological findings in cases of alleged sexual assault. Forensic Science International, 222, 154-161.
20. Marin, S.J., Hughes, J.M., Lawlor, B.G., Clark, C.J., McMillin, G.A. (2012) Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS. Journal of Analytical Toxicology, 36, 477-486.
21. Crews, B.O., Pesce, A.J., West, R., Nguyen, H., Fitzgerald, R.L. (2012) Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. Journal of Analytical Toxicology, 36, 601-607.
22. Guale, F., Shahreza, S., Walterscheid, J.P., Chen, H.H., Arndt, C., Kelly, A.T. et al. (2013) Validation of LCTOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. Journal of Analytical Toxicology, 37, 17-24.
23. Moriya, F. (2009) Urine levels of drugs for which Triage DOA screening was positive. Legal Medicine, 11, S434-S436.
24. Enno, F., Joseph, V.L. (2009) Pharmacology and abuse cocaine, amphetamines, ecstasy and related designer drugs. Dordrecht/ Heidelberg/London/New York: Springer, pp. 253-260.
25. Department of Health, Executive Yuan (2008) Regulations Governing Drug Abuse Urine Testing Operations. Taiwan, ROC: Department of Health, Executive Yuan. http://dohlaw.doh.gov.tw/Chi/EngContent. asp?Msgid=114&KeyWord=(28 March 2013, date last accessed).
26. Rivier, L. (2003) Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatographymultiple mass spectrometry in forensic toxicology and doping analysis. Analytica Chimica Acta, 492, 69-82.